Justice Dept Tweaks Crime Victim Feedback Forms Online

2026-06521 — Importer of Controlled Substances Application: Lipomed/LGC Standards

Lipomed/LGC Standards wants to become an official importer of certain controlled substances, like 3-Fluoro-N-methylcathinone. This means companies involved with these drugs can comment or ask for a hearing by May 4, 2026. If approved, it could impact how these substances enter the U.S., but no direct costs are mentioned yet.

2026-06523 — Designation of P2P Methyl Glycidic Acid as a List I Chemical

Starting May 4, 2026, anyone handling P2P methyl glycidic acid—a key chemical used to make illegal drugs like methamphetamine—must follow new government rules and register with the DEA. This means all transactions, big or small, will be closely watched to stop illegal drug production. Businesses dealing with this chemical should act fast to stay legal and avoid penalties.

2026-06329 — Notice of Lodging of Proposed Material Modification of Consent Decree Under the Clean Water Act

The City of Columbia, South Carolina, must finish four new sewer projects by January 1, 2029, to fix its sewer system and delay a related cleanup program until those projects are done. This change updates a 2014 agreement to stop sewer overflows and protect local water. People have 30 days from April 2, 2026, to share their thoughts on this plan.

2026-06051 — Importer of Controlled Substances Application: Usona Institute

Usona Institute wants to become an official importer of some powerful controlled substances like mescaline and psilocybin. People who make or use these drugs can share their thoughts or ask for a hearing by April 29, 2026. This move could impact research and medical use, with no direct cost changes announced yet.

2026-06118 — Agency Information Collection Activities; Proposed eCollection eComments Requested; Reinstatement, With Change, of a Previously Approved Collection for Which Approval Has Expired: Census of Prosecutor Offices

The Department of Justice is bringing back the Census of Prosecutor Offices with some updates to make it easier and faster to fill out. This survey affects prosecutor offices across the country and helps gather important info to improve justice stats. Comments on the changes are open until May 29, 2026, and the new process aims to save time and reduce hassle.

2026-05912 — Bulk Manufacturer of Controlled Substances Application: SpecGx LLC

SpecGx LLC wants to become a big-time maker of some powerful and tightly controlled drugs, including things like psilocybin and fentanyl. People and companies already registered can share their thoughts or ask for a hearing by May 26, 2026. This move could shake up how these substances are made and handled, so keep an eye on the deadlines if you’re involved!

Previous: 2026-03211 — Issuance of Priority Review Voucher; Rare Pediatric Disease Product; ZEVASKYN (Prademagene Zamikeracel)

The FDA just gave a special priority review voucher to Abeona Therapeutics for their rare pediatric disease treatment, ZEVASKYN, approved in April 2025. This voucher speeds up future drug reviews, helping get important medicines to patients faster. It’s a big win for kids with rare diseases and could save time and money in bringing new treatments to market.

Next: 2026-03213 — Determination That TOLECTIN DS (Tolmetin Sodium) Capsule, Equivalent to 400 Milligrams Base, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness

The FDA has decided that TOLECTIN DS (tolmetin sodium) 400 mg capsules weren’t taken off the market because of safety or effectiveness problems. This means generic drug makers can now apply to sell their own versions, as long as they meet all the rules. Patients and pharmacies could see more affordable options soon, with no safety worries holding things back!